Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Radiol ; 81(6): 1371-5, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21439744

RESUMO

PURPOSE: To compare clinical and imaging outcomes after uterine fibroid embolization (UFE) with Embosphere versus Bead Block microspheres. MATERIALS AND METHODS: Our institutional review board approved this HIPAA-compliant study. We conducted a retrospective review of all consecutive UFEs performed for symptomatic uterine fibroids at our academic institution from 2001 to 2008. UFE was performed using Embosphere (n = 70) or Bead Block (n = 55) microspheres. Patient symptoms and MR images were reviewed before and following UFE. The MR images were analyzed for changes in the size and contrast enhancement of the dominant fibroid and the uterus. RESULTS: 125 patients underwent UFE. Pre-treatment characteristics (patient age, presenting symptoms, fibroid location, and volume of the largest fibroid) were similar across groups. Procedure endpoint (near-stasis, reached in 94% of cases), duration, and sedation medication doses were also similar. Clinical follow-up was available in 69 (55%) patients (mean duration: 13.6 months). Of these, 92% had clinical improvement of their main presenting symptom(s) and 3% developed early menopause. MRI follow-up was available in 105 (84%) patients (mean 7.8 months). Mean volume reduction of the largest fibroid was similar after Embosphere (48%) and Bead Block (53%, p = NS). Residual enhancement ≥ 5% in the dominant fibroid was similarly uncommon after Bead Block (19%) or Embosphere (16%, p = NS). Mean uterine volume reduction was similar across groups (38%); no myometrial infarction occurred. CONCLUSION: This retrospective study showed no superiority of Embosphere over Bead Block microspheres in terms of clinical and imaging outcomes after UFE.


Assuntos
Resinas Acrílicas/administração & dosagem , Embolização Terapêutica/métodos , Gelatina/administração & dosagem , Hemostáticos/administração & dosagem , Leiomioma/terapia , Imageamento por Ressonância Magnética/métodos , Microesferas , Álcool de Polivinil/administração & dosagem , Neoplasias Uterinas/terapia , Adulto , Meios de Contraste , Feminino , Humanos , Leiomioma/patologia , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Neoplasias Uterinas/patologia
2.
Clin Imaging ; 35(1): 1-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21237413

RESUMO

To characterize pulmonary vein (PV) anatomy and the relative position of the PV ostia to the adjacent thoracic vertebral bodies, two readers reviewed 176 computed tomography pulmonary venous studies. PV ostial dimensions were measured and PV ovality assessed. Anatomical variations in PV drainage were noted. The position of the PV ostium relative to the nearest vertebral body edge was recorded. Right PV ostia were significantly more circular than the left (p<.001). Anatomical variability was greater for right PVs: 82% of patients had 2 ostia, 17% had 3 ostia, 0.5% had 4 ostia and 0.5% a common ostium. For left PVs, 91% of patients had 2 ostia, 8.5% a common ostium and 0.5% 3 ostia. Mean ostial distances from vertebral margin were: right PVs 3.62±7.48 mm; left PVs 3.84±8.46 mm (p=.72). 65% of right upper PV, 60.5% of right lower PV, 51% of left upper PV and 57% of left lower PV ostia were positioned lateral to vertebral bodies. Right PV ostia are rounder than left-sided and right PV drainage is more variable. As a significant proportion of PV ostia overlap the vertebral bodies, prior anatomical evaluation by CT can assist catheter ablation procedures for atrial fibrillation (AF), especially when performed under fluoroscopy.


Assuntos
Fibrilação Atrial/diagnóstico por imagem , Fibrilação Atrial/cirurgia , Ablação por Cateter/métodos , Veias Pulmonares/diagnóstico por imagem , Veias Pulmonares/cirurgia , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Feminino , Sistema de Condução Cardíaco/anormalidades , Sistema de Condução Cardíaco/diagnóstico por imagem , Sistema de Condução Cardíaco/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Veias Pulmonares/anormalidades , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Cirurgia Assistida por Computador/métodos , Resultado do Tratamento
3.
Int J Radiat Oncol Biol Phys ; 78(3): 715-21, 2010 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-20171812

RESUMO

PURPOSE: To describe the MRI appearances of squamous cell carcinoma of the anal canal before and after chemoradiation and to assess whether MRI features predict for clinical outcome. METHODS AND MATERIALS: Thirty-five patients (15 male, 20 female; mean age 60.8 years) with histologically proven squamous cell cancer of the anal canal underwent MRI before and 6-8 weeks after definitive chemoradiation. Images were reviewed retrospectively by two radiologists in consensus blinded to clinical outcome: tumor size, signal intensity, extent, and TNM stage were recorded. Following treatment, patients were defined as responders by T and N downstaging and Response Evaluation Criteria in Solid Tumors (RECIST). Final clinical outcome was determined by imaging and case note review: patients were divided into (1) disease-free and (2) with relapse and compared using appropriate univariate methods to identify imaging predictors; statistical significance was at 5%. RESULTS: The majority of tumors were ≤T2 (23/35; 65.7%) and N0 (21/35; 60%), mean size 3.75 cm, and hyperintense (++ to +++, 24/35 patients; 68%). Following chemoradiation, there was a size reduction in all cases (mean 73.3%) and a reduction in signal intensity in 26/35 patients (74.2%). The majority of patients were classified as responders (26/35 (74.2%) patients by T and N downstaging; and 30/35 (85.7%) patients by RECIST). At a median follow-up of 33.5 months, 25 patients (71.4%) remained disease-free; 10 patients (28.6%) had locoregional or metastatic disease. Univariate analysis showed that no individual MRI features were predictive of eventual outcome. CONCLUSION: Early assessment of response by MRI at 6-8 weeks is unhelpful in predicting future clinical outcome.


Assuntos
Neoplasias do Ânus/patologia , Carcinoma de Células Escamosas/patologia , Imageamento por Ressonância Magnética , Canal Anal/patologia , Análise de Variância , Neoplasias do Ânus/tratamento farmacológico , Neoplasias do Ânus/radioterapia , Carcinoma de Células Escamosas/tratamento farmacológico , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/secundário , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Estadiamento de Neoplasias , Estudos Retrospectivos , Resultado do Tratamento , Carga Tumoral
4.
AJR Am J Roentgenol ; 191(6): W288-92, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19020217

RESUMO

OBJECTIVE: The purpose of this study was to determine how the temporal interval between scan acquisitions influences quantitative perfusion CT vascular parameters in colorectal cancer. SUBJECTS AND METHODS: Forty-five patients with colorectal adenocarcinoma prospectively underwent a 65-second single-anatomic-level perfusion CT study. Blood flow, blood volume, transit time, and permeability-surface area product for a 2-cm tumor coverage were determined with commercial software based on distributed parameter analysis for four temporal intervals (1, 2, 3, and 4 seconds) between acquisitions. Mean vascular values obtained for these intervals were compared by use of analysis of variance with posttesting by the Bonferroni method. Statistical significance was set at 5%. RESULTS: Mean +/- SD blood flow, volume, transit, and permeability-surface area product were 71.5 +/- 34.8 mL/min/100 g tissue, 6.33 +/- 1.96 mL/100 g tissue, 10.8 +/- 5.54 seconds, and 14.9 +/- 3.51 mL/min/100 g tissue, respectively, at 1 second; 86.6 +/- 40.6 mL/min/100 g tissue, 6.30 +/- 2.53 mL/100 g tissue, 10.7 +/- 7.12 seconds, and 14.5 +/- 3.55 mL/min/100 g tissue at 2 seconds; 97.8 +/- 42.7 mL/min/100 g tissue, 5.98 +/- 1.72 mL/100 g tissue, 8.11 +/- 4.37 seconds, and 14.5 +/- 3.58 mL/min/100 g tissue at 3 seconds; and 108.8 +/- 46.0 mL/min/100 g tissue, 6.69 +/- 3.46 mL/100 g tissue, 7.12 +/- 3.54 seconds, and 13.9 +/- 3.49 mL/min/100 g tissue at 4 seconds. Blood flow was overestimated (p = 0.0002) and transit underestimated (p = 0.03) with lengthening acquisition interval. Posttesting revealed that in a comparison with 1-second data, this difference was significant for 3- and 4-second data for blood flow and 4-second data for transit. CONCLUSION: Increasing the temporal interval from 1 to 4 seconds leads to overestimation of tumor blood flow and underestimation of blood transit in distributed parameter analysis. Use of the helical perfusion CT techniques being developed may lead to inaccurate assessment unless the acquisition interval is shorter than 3 seconds.


Assuntos
Adenocarcinoma/diagnóstico por imagem , Neoplasias Colorretais/diagnóstico por imagem , Imagem de Perfusão do Miocárdio/métodos , Neovascularização Patológica/diagnóstico por imagem , Intensificação de Imagem Radiográfica/métodos , Tomografia Computadorizada Espiral/métodos , Adenocarcinoma/irrigação sanguínea , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Colorretais/irrigação sanguínea , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA